Nobels-Janssen, E. http://orcid.org/0000-0001-9725-2842
Postma, E. N.
Abma, I. L.
van Dijk, J. M. C.
Haeren, R.
Schenck, H.
Moojen, W. A.
den Hertog, M. H.
Nanda, D.
Potgieser, A. R. E.
Coert, B. A.
Verhagen, W. I. M.
Bartels, R. H. M. A.
van der Wees, P. J.
Verbaan, D.
Boogaarts, H. D.
Article History
Received: 30 August 2021
Revised: 26 October 2021
Accepted: 26 October 2021
First Online: 8 November 2021
Declarations
:
: The authors report no disclosures relevant to the manuscript. WA Moojen has no personal funding, but the department is part of two clinical trials (researchers initiative) sponsored by Takeda and the Dutch Brain Foundation (“Hersenstichting”). HD Boogaarts is consultant for Stryker neurovascular; fees are paid to the institution.
: Ethical approval was not required for this type of study under Dutch law, and an exemption was obtained by the local Medical Ethics Committee (CMO region Arnhem-Nijmegen, file number 2018–4184).
: All patients or their representatives gave written informed consent.
: Not applicable.